Cite
MLA Citation
Mark Sulkowski et al.. “1223Ledipasvir/Sofosbuvir is Safe and Effective as a Single-Tablet-Regimen for Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus, Including those with Compensated Cirrhosis.” Open forum infectious diseases, vol. 1, n.d., p. S42. http://access.bl.uk/ark:/81055/vdc_100135170088.0x000021